MARKET

AIM

AIM

Aim Immunotech
AMEX
1.130
-0.130
-10.32%
Closed 19:54 12/31 EST
OPEN
1.190
PREV CLOSE
1.260
HIGH
1.220
LOW
1.070
VOLUME
478.11K
TURNOVER
23.88K
52 WEEK HIGH
25.40
52 WEEK LOW
1.070
MARKET CAP
3.22M
P/E (TTM)
-0.0570
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 12/31/2025 20:00
AIM ImmunoTech Declares 1-For-1,000 Stock Dividend For Shareholders And Option/Warrant Holders
Benzinga · 12/30/2025 22:20
*AIM ImmunoTech: One Shr for Every 1,000 Shrs or for Every Outstanding Option or Warrant Having a Right to Stk Dividends >AIM
Dow Jones · 12/30/2025 22:12
Press Release: AIM ImmunoTech Announces Stock Dividend
Dow Jones · 12/30/2025 22:10
*AIM ImmunoTech Announces Stk Div >AIM
Dow Jones · 12/30/2025 22:10
AIM ImmunoTech Announces Stock Dividend
Barchart · 12/30/2025 16:10
Weekly Report: what happened at AIM last week (1222-1226)?
Weekly Report · 12/29/2025 09:56
Weekly Report: what happened at AIM last week (1215-1219)?
Weekly Report · 12/22/2025 09:56
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharma company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immuno-modulator, which is being developed for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.